by Fritz Esker, Contributing Writer | Louisiana Weekly
Pharmaceutical giant Pfizer has become famous during the COVID-19 pandemic for their vaccines, but they have also been spreading awareness about a lesser-known-but-still-fatal condition called transthyretin amyloid cardiomyopathy (ATTR-CM). It’s a condition in which 90 percent of the victims are Black.
As part of the effort to spread awareness about ATTR-CM, Pfizer awarded $46,500 in sponsorship funding to the Minority Health Institute, Inc. (mhinst.org) to hold a town hall program called Voices for the Heart. According to data from the MHI, ATTR-CM affects four percent of the Black population in the United States, about 1.5 million people.
In the latest town hall in the series, Dr. Russell Ledet of Docs on Da Block discussed ATTR-CM on December 15. Ledet said ATTR-CM is often undiagnosed and misdiagnosed. The symptoms of the disease are often mistaken for other issues. For example, carpal tunnel syndrome
Click to read the full article @New Pittsburgh Courier